Release date: 2014-08-15
Recently, the Ebola virus epidemic has caused high vigilance in countries around the world. This deadly virus has caused thousands of deaths in Africa. The WHO recently announced that it will position Kenya in a high-risk country in Ebola. An official said that Kenya, as an important transit point in West Africa, is a high-risk area for the spread of the Ebola epidemic. As of now, 1,069 people in West Africa have died from the Ebola virus. In order to control this epidemic, governments around the world have taken measures such as Canada's emergency support to Africa for 1,000 Ebola vaccines under development, and Germany has waited for the government to warn its residents not to go to these high-risk countries. This is the first time that the Ebola epidemic has spread to West Africa. The Ebola epidemic has mainly occurred in Central Africa and East Africa.
The epidemic has once again caused governments around the world to put anti-Ebola drugs on the agenda. There are currently only two drugs in the world that have an effect on this virus. The first is Zmapp, a cocktail therapy drug that works primarily on proteins on the surface of Ebola. The second is TKM-Ebola, which blocks the replication of Ebola virus genetic material and is currently in early clinical research. The FDA had previously asked the drug to conduct a more in-depth study to determine its safety and efficacy.
Ebola virus can cause symptoms such as bleeding, high fever and damage to the central nervous system. The incubation period is about 2-15 days. The mortality caused by the Ebola virus is more than 90%, but the mortality rate of the epidemic is currently maintained at around 55%. There are currently no effective vaccines and therapies for this disease. The fruit bat is considered to be the original host of this virus.
Source: Bio Valley
Half Shell Mussel,Frozen Cooked Half Shell Mussel,Seafood Frozen Half Shell Mussel,Frozen Half Shell Mussel
Shengsi Huali Aquatic Products Co.,Ltd , https://www.mytilus-edulis.com